After decades of research with few breakthroughs, eight multiple sclerosis drugs are slowing disease progression and helping patients manage their conditions. Though first-generation immune-suppressing drugs are still in use, newer drugs target specific molecules associated with MS, and others that prevent nerve damage are in late stages of development. "We have a disease that's gone from having no treatments 20 years ago to having multiple treatment options," said National Multiple Sclerosis Society Chief Research Officer Dr. Timothy Coetzee.

Related Summaries